Any stock, in context
ANTHEM · Healthcare
Anthem Biosciences Ltd.
Observation · 15 Oct 2026
How these are readAnthem Biosciences closed at ₹842.1 on 15 Oct 2026, 11.4% above its 200-day average and 5.5% below its 50-day average: above the long line, below the short one. It sits 12.1% below its highest close of the past year, in the fourth fifth of its one-year range. Over three months it rose 8.4%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +11.4%
- the long line
- vs 50-day
- −5.5%
- the short line
- From 52w high
- −12.1%
- ₹579.2₹977.6
- 3 months
- +8.4%
- sector median −2.7% · 43 of 146
Nifty Midcap 150 · Healthcare · EQ series · median traded value ₹51 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −0.67%
- 1W
- –
- 1M
- −10.69%
- 3M
- +8.38%
- YTD
- –
- 1Y
- +8.86%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.